-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Chemours, Lowers Price Target to $18

Benzinga·09/30/2026 13:32:05
Mizuho analyst John Roberts maintains Chemours (NYSE:CC) with a Outperform and lowers the price target from $20 to $18.